MEDCRYST

MedCryst Therapeutics was founded in 2017 by Dr Mark Hooper and is dedicated to developing new treatments for the inflammatory arthritis condition of gout. The company is centred around the concept of applying basic chemistry and formulation principles to the challenge of helping cryst als of an organic salt (mono-sodium urate) to dissolve in a med ical setting, hence MedCryst Therapeutics... Over the last years, we have developed various lead formulations that show real promise in the laboratory environment based on previously used and tested ingredients (excipients). The next stage is to launch our first product - "Gout Buster Gel".

Primary location: Oxford United Kingdom